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Serum IgG subclasses levels in paediatric patients with pneumonia
*LR MAZENGERA, * *KJ NATHOO, *** S RUSAKANIKO, **** BJM ZEGERS
wards with pneumonia.
Design: A cross sectional study.
Setting: Harare Central Hospital, Departments of Immunology and Paediatrics, University of Zimbabwe; 
- Department of Paediatric Immunology, University of Utrecht, The Netherlands.
Subjects: 56 paediatric patients.
Main Outcome Measures: IgG subclass profiles of children with pneumonia.
Results: Of the 56 children tested, 40 (71%) had antibodies to human immunodeficiency virus (HIV). The 
levels of IgGl and IgG3 subclasses were significantly higher in HIV antibody positive children (p<0.001, 
p<0.01 respectively) than in those without detectable HIV antibodies in their sera. There was no significant 
relationship between IgG subclass levels and the presence of HIV p24 antigen. Furthermore, age and gender 
also had no significant influence on the levels of IgG subclasses in this population.
Conclusion: High levels of IgGl and IgG3, but not IgG2 .and IgG4, occur frequently in children with 
pneumonia and are associated with the presence of HIV antibodies.
Abstract
Objectives: To determine the IgG subclass levels of patients admitted to Harare Central Hospital paediatric
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Introduction More recent studies6,7 have shown that the concentrations 
of total IgGl and IgG3, in various mucosal fluids, are 
increased in HIV-infected individuals while those of IgG2' 
and IgG4 are decreased. Furthermore, the concentrations 
of specific IgGl and IgG3 antibodies to HIV virus are 
correspondingly increased in the same HIV-infected 
subjects while specific IgG2 and IgG4 antibodies were 
reduced. It is now established that IgG2 type antibodies are 
the most effective against encapsulated bacteria such as 
Streptococcus pneumoniae, particularly in young children.s 
It would appear that children with low IgG2 levels would 
have correspondingly low levels of IgG2-type antibodies
Bacterial pneumonia is the commonest cause of morbidity 
and mortality in Zimbabwe.1 The children most at risk are 
those infected with HIV.2-4 We reported, in a recent study2 
that the great majority of children admitted to hospital with 
pneumonia have hypergam m aglobulinaem ia in 
immunoglobulins A (IgA), G (IgG) and M (IgM). IgG was 
the most raised immunoglobulin class with concentrations 
of up to 10 times that of normal age-matched reference 
ranges. The report was in agreement with other studies 
done previously.3,5
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and therefore a deficient humoral immune response to 
encapsulated bacteria. Such a deficient immune response 
, would be further compromised by HIV infection.
The main objective of this study was to investigate the 
relationship between levels of IgG subclasses and the 
occurrence of pneumoilia in children aged one month to six 
years with or without evidence of HIV infection.
Material and Methods
Patients.
The study population consisted of children, between the 
ages of one month and six years, admitted to hospital with 
pneumonia. The diagnosis of pneumonia was based on the 
World Health Organisation (WHO) clinical definition 
consisting of cough associated with difficulty in breathing.9 
Fifty six children with pneumonia, selected consecutively 
over a period, of five months, were included in the study. 
Ghildren with a history of asthma were excluded from the 
study. Parental consent was sort for all children used in the 
study.
Collection of Blood Samples. (
Between two and five mis of venous blood was taken 
from each child into a plain tube for clotting. Serum was 
separated, aliquoted and stored at -20°C.
IgG Subclass Determinations.
IgGl, IgG2, IgG3 and IgG4 were measured by radial 
immunodiffusion (RID) assay using kits purchased from 
Binding Site (Birmingham, United Kingdom). All assays 
were performed according to the m anufacturers’ 
instructions. Briefly, equal volumes of serum from the 
patients were added to separate wells of the RID plates and 
the plates incubated at 37°C for 16 hours. Diameters of 
precipitin rings formed were measured with the aid of a 
magnifying glass and the concentrations calculated against 
the standards. Levels of these immunoglobulin subclasses 
were expressed in milligrams permillilitre (mg/ml). Normal 
reference ranges (+2SD) were taken from the publication 
entitled ‘Handbook of Clinical Immunology Service’10 
used in routine Immunology'Labs in Zimbabwe’s Public 
Health Laboratories.
HIV Screening.
Serum from each patient was tested for HIV using three 
different enzyme-linked immunosorbent assay (ELISA) 
kits. All assays were performed in accordance with the 
manufacturers’ instructions. Two independent HIV ELISA 
antibody kits (Genelavia, Sanofi Diagnostics, Pasteur, 
France; Human, Wiesbaden, Germany) were used to 
determine the presence of antibodies to HIV 1/2. Briefly, 
serum from each patient sample was incubated in HIV1/2 
antigen-coated wells. After washing, an antibody-enzyme 
conjugate to human IgG was added and a second incubation 
done followed by further washing. A final incubation step 
with the enzyme substrate was done and colour development 
read at 405nm on the Coda Automated EIA Analyser 
(Biorad Laboratories, Hertfordshire, UK).
Because of persistence of maternal antibodies in children 
up to the age of about 18 months, a third HIV screening
test, an HIV ELISA antigen test (Murex Chatillon, France), 
which detects the presence of the p24 antigen shed from the 
HIV 1 virus,11 was used. Briefly, the method used was 
similar to the one above except that the ELISA pi ate wells 
were.coated with antibody to the HIV Vims
Results
Of the 56 patients studied, 40 (11%) had antibodies to HIV 
while 16 (29%) had no detectable antibodies to HIV. Of the 
40 with antibodies to HIV, 22 had detectable HIV p24 
antigen in their sera. HIV p24 antigen was not detected in 
any of the 16 HIV antibody negative patients. Although 
there was substantial variation between individuals in the 
levels of IgG subclasses, IgGl subclass concentrations 
were markedly higher in HIV antibody positive (HIV Ab+) 
than in HIV antibody negative (HIV Ab') patients (see 
Table I). Even when the medians for the IgG subclasses 
were compared between the HIV Ab-i- and HIV A b', as 
Table II shows, IgG l and IgG3 median levels are 
significantly higher (p<0.001 for each of the 2 subclasses) 
in HIV Ab+ patients. We found no significant differences 
in the levels of IgG2 and IgG4 between HIV Ab+ and HIV 
Ab' patients.
Table I: A comparison of IgG subclass means between HIV 
Ab* and HIV Ab- children admitted to hospital with 
pneumonia.
n
Mean (SD) 
IgG 1 
mg/ml
Mean (SD) 
IgG 2 
mg/ml
Mean (SD) 
IgG 3 
mg/ml
Mean(SD) 
IgG 4 
mg/ml
01-06months
HIV Ab* 18 25.32 (15.33) 3 .15 (1 .55 ) 1 .80 (0 .87 ) 0 .127(0 .1 .2 )
HIV Ab' 3 9.64 (4.85) 2 .24 (1 .10 ) 1.11 (0.07) 0 .15 (0 .15 )
07-12 months
HIV Ab* 5 47.1 (19.80) 4.45 (2.6) 1.41 (0.53) 0 .35 (0.26) '
HIV Ab' 4 4.08 (1.34) 1.92 (1.41) 0 .62 (0.13) 0 .30 (0.31)
13-18 months
HIV Ab* 6 20 .18(14 .12) 1.82 (1.35) 0 .95 (0.96) 0 .16 (0 .14 )
HIV Ab' 3 . 3 .86 (0.93) 1.50 (1.02 0 .53 (0 .10 ) 0.21 (0.16)
>18 months
HIV Ab* 11 27.07 (15.65) 2 .13 (0.60) 2 .28 (1 .31 ) 0.22 (0.27)
HIV Ab' 6 6 .15 (1 .27 ) . 1.43 (0.63) 0 .78 (0 .41 ) 0.21 (0.11)
Reference Ranges:'0 
IgG su bclasses
A g e : . IgGl (mg/ml lgG2(mg/ml) lgG3 (mg/ml) lgG4 (mg/ml)
6 m onths 1.5-3.0 0.3-0.5 0.1-0.6 <0.1
2 years 2 .3 S .8 0.3-2.9 0.1-0.8 <0.8
Table II: A comparison o f IgG subclass medians between 
HIV Ab* and HIV Ab' children admitted to hospital with 
pneumonia. > -
HIV Ab* group (n=40) HIV Ab' group (n=16)
Median (01-03) mg/ml Median (01-03) mg/ml p-value
IgG l 24 .85(16.45-34.05) 5.48 (4.1-6.1) <0.001
!gG2 2.35 (1.69-3.56) 1 .122(0 .78-2 .6) 0.024
lgG3 1.71 (1.20-2.09) 0.67 (0 .46-142) <0.001
igG4 0.13 (0.03-0.25) 0.15 (0.09-0.34) 0.24
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IgG subclass levels were also.compared between HIV 
p24 antigen positive (HIVAg+) patients and those without 
detectable p24 antigen in their sera (HIVAg"), in the same 
population group; Of the 56 patients, 22 (39%) were HIV 
Ag+ while 34 (61%) were HIVAg'. No significant 
differences were observed in the mean concentrations of 
each subclass between the two groups, as Table III shows. 
Similarly, no significant differences were observed when 
the medians of the IgG subclasses were compared between 
HIV Ag+ and HIV Ag'patients (Table IV).
Table III: A comparison of IgG subclass means between 
HIVAg+ and HIV Ag children admitted to hospital with 
pneumonia
n
Mean (SD) 
IgG 1 
mg/ml
Mean (SD) 
IgG 2 
mg/ml
Mean (SD 
IgG 3
mg/ml
Mean (SD) 
IgG 4 
mg/ml
01-06 months
HIVAgt 11 22.35 (15.11) 2 .95 (1 .19 ) 1.69 (0.50) 0 .16 (0 .13 )
H IVAg- 10 23.88 (15.53) 3 .09 (1 .83 ) 1.71 (0.09) 0.12(0.13)
07-12 months
HIVAg’ 0 __ __ ' _ _
HIVAg- 89 29.98 3.33(2.50) 1.05 (0.56) 0.32(0.29)
13-16 months
HIV Ag+. . 3 20.12 (15.11) 1.48(0.61) 0.35 (0.32) 0.17(0.11)
HIVAg- 6 12.05 (12.36) 1.83(1.46) 1 .04 (0 .88 ) 0 .18 (0 .16 )
<18 months
HIV Ag+ 8 25.03 (7.99) 2.27(0.59) 2.33(1.53) ’ 0.16(0.12)
HIVAg- 9 14.97(19.66) 1.54(0.59) 1 .23 (0 .74 ) 0.26(0.29)
Reference Ranges:"1 
IgG sub cla sses
Age: lgG1(mg/ml) lgG2(mg/ml) lgG3(mg/ml) lgG4(mg/ml)
6 m onths 1.5-3.0 0.3-0.5 0.1-0.6 <0.1
2  years 2.3-S.8 0.3-2.9 0.1-0.8 <0.8
Table IV: A comparison o f IgG subclass medians between 
HIV Ag* and HIV Ag: children admitted to hospital with 
pneumonia.
HIV Ab; group (n=40) 
Median (Q1-Q3) mg/ml
HIV Ab- group (n=16) 
Median (Q1-Q3) mg/ml p-value
IgGl 2 0 .1 5 (1 6 .3 0 -2 8 .2 0 ) 8.43  (5.12-32.4) 0.18
lgG2 2.41 (1.69-3.15) 1.92  (1.15-3.49) 0.39
lgG3 1.57 (1.20-2.00) 1 .16(0 .46 -2 .01 ) 0.13
igG 4 1.15 (0.03-0.23) 0 .13(0 .06-0 .31 0.77
The results were then subjected to multipfe regression 
analysis with respect to age, gender, HIV Ab status and 
HIV Ag status. The coefficients of variation calculated 
across the IgG subclasses (see Table V) clearly showed 
that abnormally high levels.of IgGl and IgG3 in the 
patients studied were significantly associated with the 
presence of antibodies to HIV (p-values of <0.001 and
0.010, respectively). Age, gender and the presence of HIV 
p24 antigen had no significant influence on the levels of the 
IgG subclasses in this population.
Table V: Regression modelling of IgG subclass levels in 
children with pneumonia.
Constant Age Gender HIV Ab HIVAg p value
lgG1 11.67 -0.03 -7.82 24.22* -9.14 <0.001
igG2 2.14 -0.02 0.66 -0.66 0.34 0.094
igG3 1.84 0.01 0.44 -0.93* 0.01 0.010
lgG4 -0.11 0.00 . 0,12 0.04 0.05 0.283
* Indicates significant predictors in the model.
Discussion
The present study has established the pattern of distribution 
of IgG subclasses in children admitted to Harare Hospital 
with pneumonia, with or without evidence of HIV co- 
infection. Abnormally high levels IgGl and IgG3 were 
significantly associated with the presence of HIV antibodies. 
The association between the levels of IgG2 and the presence 
of HIV antibody was not significant. Similarly, we did not 
find any association between the levels of IgG4 and the 
presence of HIV antibodies. To our knowledge, this is the 
first study of its kind to be conducted in Zimbabwe and the 
results are in agreement with other recently published 
reports.6'7
Factors such as age, gender and the presence or absence 
of HIV-p24 antigen did not appear to influence the pattern 
of IgG subclass levels in our study population. The apparent 
lack of association between levels of IgG subclasses and 
presence or absence of HIVp-24 antigen may be due to 
lower sensitivities of the p-24 assays12 compared to those 
of established HIV antibody assays.
HIV antibody tests are the most widely used in adult 
subjects to screenfor HIV. Such methods are not conclusive 
in children under the age of 18 months, because of 
persistence of maternally acquired antibodies.13' 14' 
Furthermore,. HIV-p24 antigen tests have their limitations 
too as high sensitivities of about 80% appear to be achievable 
only in infants of up to two months — beyond that age the 
sensitivities tend to progressively diminish although 
specificity remains high.12 Our results clearly suggest that 
abnormally raised IgGl and IgG3 in children presenting 
with pneumonia appear to be strongly suggestive of 
concurrent HIV infection. Used as a diagnostic tool, IgGl 
profiles would be relatively cheaper, particularly in the 
developing world, compared to other conventional 
techniques.
A recent study supports the same view.15 Although the 
presence of abnormally high levels of IgGl and IgG3 will 
not conclusively prove that a child is infected with HIV, 
but taken together with the mother’s HIV antibody status 
could strengthen the clinician’s suspicion that there might 
be underlying HIV infection. Appropriate clinical 
management regimes could then be applied to those children 
at risk found to have high IgGl and IgG3 levels.
A future study could look at profiles of neutralising 
antibody isotypes in children born to HIV seropositive 
mothers in a longitudinal study. Special focus would be
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given to those children who remain or become seronegative 
with time.
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